持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/01/07 | 3,925 | 3,925 | 3,865 | 3,870 | -10 | -0.3% | 43,600 |
| 2021/01/06 | 3,850 | 3,900 | 3,825 | 3,880 | +20 | +0.5% | 15,500 |
| 2021/01/05 | 3,890 | 3,890 | 3,845 | 3,860 | -40 | -1% | 26,400 |
| 2021/01/04 | 3,935 | 3,935 | 3,855 | 3,900 | -25 | -0.6% | 24,400 |
| 2020/12/30 | 4,000 | 4,000 | 3,925 | 3,925 | -85 | -2.1% | 33,700 |
| 2020/12/29 | 3,895 | 4,010 | 3,895 | 4,010 | +125 | +3.2% | 42,400 |
| 2020/12/28 | 3,895 | 3,900 | 3,845 | 3,885 | +30 | +0.8% | 30,900 |
| 2020/12/25 | 3,855 | 3,865 | 3,835 | 3,855 | +20 | +0.5% | 17,300 |
| 2020/12/24 | 3,870 | 3,905 | 3,830 | 3,835 | +5 | +0.1% | 32,400 |
| 2020/12/23 | 3,935 | 3,940 | 3,820 | 3,830 | -65 | -1.7% | 86,600 |
| 2020/12/22 | 3,890 | 3,925 | 3,855 | 3,895 | -15 | -0.4% | 38,200 |
| 2020/12/21 | 3,975 | 4,010 | 3,895 | 3,910 | -40 | -1% | 31,200 |
| 2020/12/18 | 3,900 | 3,970 | 3,890 | 3,950 | +65 | +1.7% | 64,700 |
| 2020/12/17 | 3,920 | 3,920 | 3,870 | 3,885 | -35 | -0.9% | 40,500 |
| 2020/12/16 | 4,005 | 4,005 | 3,920 | 3,920 | -75 | -1.9% | 35,900 |
| 2020/12/15 | 4,005 | 4,020 | 3,970 | 3,995 | -40 | -1% | 26,400 |
| 2020/12/14 | 3,990 | 4,060 | 3,990 | 4,035 | +45 | +1.1% | 39,000 |
| 2020/12/11 | 3,925 | 3,990 | 3,920 | 3,990 | +70 | +1.8% | 34,600 |
| 2020/12/10 | 3,915 | 3,930 | 3,885 | 3,920 | +5 | +0.1% | 30,000 |
| 2020/12/09 | 3,915 | 3,935 | 3,895 | 3,915 | ±0 | ±0% | 34,300 |
| 2020/12/08 | 3,930 | 3,960 | 3,895 | 3,915 | -20 | -0.5% | 36,400 |
| 2020/12/07 | 3,945 | 3,945 | 3,905 | 3,935 | +30 | +0.8% | 42,000 |
| 2020/12/04 | 3,935 | 3,975 | 3,885 | 3,905 | -30 | -0.8% | 52,500 |
| 2020/12/03 | 3,965 | 3,985 | 3,920 | 3,935 | -45 | -1.1% | 60,600 |
| 2020/12/02 | 4,035 | 4,035 | 3,960 | 3,980 | -20 | -0.5% | 86,200 |
| 2020/12/01 | 4,055 | 4,090 | 3,955 | 4,000 | -10 | -0.2% | 63,900 |
| 2020/11/30 | 4,095 | 4,135 | 4,005 | 4,010 | -115 | -2.8% | 71,200 |
| 2020/11/27 | 4,095 | 4,170 | 4,085 | 4,125 | +50 | +1.2% | 69,500 |
| 2020/11/26 | 4,065 | 4,105 | 4,030 | 4,075 | +5 | +0.1% | 44,800 |
| 2020/11/25 | 4,110 | 4,125 | 4,060 | 4,070 | -25 | -0.6% | 60,300 |
| 2020/11/24 | 4,175 | 4,230 | 4,090 | 4,095 | +5 | +0.1% | 70,000 |
| 2020/11/20 | 4,080 | 4,120 | 4,050 | 4,090 | -15 | -0.4% | 36,100 |
| 2020/11/19 | 4,145 | 4,145 | 4,065 | 4,105 | -65 | -1.6% | 45,500 |
| 2020/11/18 | 4,115 | 4,175 | 4,085 | 4,170 | +35 | +0.8% | 35,400 |
| 2020/11/17 | 4,150 | 4,150 | 4,085 | 4,135 | -15 | -0.4% | 43,900 |
| 2020/11/16 | 4,135 | 4,190 | 4,110 | 4,150 | +85 | +2.1% | 51,800 |
| 2020/11/13 | 4,160 | 4,160 | 4,005 | 4,065 | -60 | -1.5% | 46,500 |
| 2020/11/12 | 4,115 | 4,145 | 4,065 | 4,125 | +10 | +0.2% | 36,400 |
| 2020/11/11 | 4,220 | 4,240 | 4,070 | 4,115 | -40 | -1% | 69,100 |
| 2020/11/10 | 4,160 | 4,195 | 4,105 | 4,155 | +40 | +1% | 70,600 |
| 2020/11/09 | 4,160 | 4,160 | 4,060 | 4,115 | -15 | -0.4% | 54,200 |
| 2020/11/06 | 4,080 | 4,160 | 4,050 | 4,130 | +20 | +0.5% | 54,400 |
| 2020/11/05 | 3,995 | 4,125 | 3,995 | 4,110 | +145 | +3.7% | 61,400 |
| 2020/11/04 | 3,940 | 4,035 | 3,935 | 3,965 | +60 | +1.5% | 89,700 |
| 2020/11/02 | 3,850 | 3,935 | 3,805 | 3,905 | +105 | +2.8% | 77,600 |
| 2020/10/30 | 3,850 | 3,850 | 3,770 | 3,800 | -80 | -2.1% | 39,400 |
| 2020/10/29 | 3,890 | 3,940 | 3,880 | 3,880 | -10 | -0.3% | 33,800 |
| 2020/10/28 | 3,835 | 3,910 | 3,810 | 3,890 | +20 | +0.5% | 34,600 |
| 2020/10/27 | 3,835 | 3,885 | 3,815 | 3,870 | +15 | +0.4% | 38,100 |
| 2020/10/26 | 3,850 | 3,940 | 3,830 | 3,855 | +5 | +0.1% | 46,100 |
951～
1000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
